Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics

Despite great progress in the management of atherosclerosis (AS), its subsequent cardiovascular disease (CVD) remains the leading cause of morbidity and mortality. This is probably due to insufficient risk detection using routine lipid testing; thus, there is a need for more effective approaches rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shuai, Xia, Mingfeng, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356911/
https://www.ncbi.nlm.nih.gov/pubmed/34395555
http://dx.doi.org/10.3389/fcvm.2021.681444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356911/
https://www.ncbi.nlm.nih.gov/pubmed/34395555
http://dx.doi.org/10.3389/fcvm.2021.681444

Ejemplares similares